logo-loader
viewShareRoot Ltd

ShareRoot notches second Australian deal, lifts financials

ShareRoot CEO Noah Abelson-Girdler says the company's second MediaConsent deal in Australia with Neuroscience Trials Australia shows the potential of further deals for its data regulation platform product.

Abelson-Girdler also says the company has slowed its cash burn and lifted revenue.

Quick facts: ShareRoot Ltd

Price: 0.001 AUD

ASX:SRO
Market: ASX
Market Cap: $2.96 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of ShareRoot Ltd named herein, including the promotion by the Company of ShareRoot Ltd in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Ludomade has already closed its first major deal under the ShareRoot umbrella

ShareRoot (ASX:SRO) CEO Noah Abelson-Gertler speaks to Proactive Investors about the addition of a fourth revenue stream through the acquisition of Ludomade Inc, the new brands that have signed on to the beta testing program for the MediaConsent platform that is now past the halfway point,...

on 30/11/18

2 min read